Concepedia

Liposome Toxicity

Liposome Toxicity is a biological risk assessment construct that denotes the adverse effects elicited by liposomal formulations due to their physicochemical properties, cellular interactions, or degradation byproducts, distinguishing it from toxicity originating solely from encapsulated agents.

623

Publications

33.2K

Citations

3K

Authors

833

Institutions

Publications per year

2017–2026

103

Parents

Publications

623

The Carrier Potential of Liposomes in Biology and Medicine

Gregory Gregoriadis · New England Journal of Medicine · 1976 · 590 citations

, , +17

Pegylated Liposomal Doxorubicin: Metamorphosis of an Old Drug into a New Form of Chemotherapy

Alberto Gabizón · Cancer Investigation · 2001 · 566 citations

, , +17

Liposome‐encapsulated doxorubicin compared with conventional doxorubicin in a randomized multicenter trial as first‐line therapy of metastatic breast carcinoma

Lyndsay N. Harris, Gerald Batist, Robert J. Belt et al. · Cancer · 2001 · 511 citations · Full text

, , +17

Protection against oxygen toxicity by intravenous injection of liposome-entrapped catalase and superoxide dismutase.

Julio F. Turrens, James D. Crapo, Bruce Α. Freeman · Journal of Clinical Investigation · 1984 · 479 citations · Full text

, , +15

Liposomal doxorubicin: antitumor activity and unique toxicities during two complementary phase I studies.

Beatrice Uziely, Susan Jeffers, Rut Isacson et al. · Journal of Clinical Oncology · 1995 · 478 citations

, , +15

1–5 of 623

Authors

3K

  1. MB
    Marcel B. Bally

    University of British Columbia, Canada

    11 publications · 683 citations

    11

    h-index

  2. EM
    E. Mayhew

    Roswell Park Comprehensive Cancer Center, United States

    10 publications · 958 citations

    10

    h-index

  3. AR
    Aquilur Rahman

    Georgetown University, United States

    9 publications · 351 citations

    9

    h-index

  4. MC
    Mônica Cristina Oliveira

    Universidade Federal de Minas Gerais, Brazil

    8 publications · 251 citations

    8

    h-index

  5. GL
    Gabriel Lopez‐Berestein

    The University of Texas MD Anderson Cancer Center, United States

    8 publications · 423 citations

    8

    h-index

1–5 of 3K

Institutions

833

  1. Georgetown University

    Washington, United States

    15 h-index

    42 publications

    2.6K citations

  2. The University of Texas MD Anderson Cancer Center

    Houston, United States

    14 h-index

    59 publications

    2.5K citations

  3. Universidade Federal de Minas Gerais

    Belo Horizonte, Brazil

    13 h-index

    70 publications

    2K citations

  4. Roswell Park Comprehensive Cancer Center

    Buffalo, United States

    13 h-index

    30 publications

    2.5K citations

  5. Georgetown University Medical Center

    Washington, United States

    13 h-index

    38 publications

    2.5K citations

  6. University of British Columbia

    Vancouver, Canada

    12 h-index

    29 publications

    1.4K citations

  7. Utrecht University

    Utrecht, The Netherlands

    10 h-index

    21 publications

    737 citations

  8. BC Cancer Agency

    Vancouver, Canada

    9 h-index

    36 publications

    2.6K citations

1–8 of 833

Venues

  1. PubMed

    Repository · 66 publications · 3.1K citations

    30

    h-index

  2. Cancer Chemotherapy and Pharmacology

    20 publications · 939 citations

    18

    h-index

  3. International Journal of Pharmaceutics

    16 publications · 850 citations

    15

    h-index

  4. Journal of Liposome Research

    22 publications · 659 citations

    13

    h-index

  5. Journal of Controlled Release

    13 publications · 1K citations

    13

    h-index

1–5